|  Post Reply

While these data, like the IES data, support the contention that switching to an AI after 2 years is superior to continuing tamoxifen, the trial is limited by its open label design, and the updated results are complicated by crossover of patients from tamoxifen to anastrozole N 82 and withdrawals during the tamoxifen therapy period dapoxetine priligy uk Bioavailability of encapsulated resveratrol into nanoemulsion based delivery systems

Add comment